±±Ê¦´óϸ°ûÉúÎïѧ£º |@pJ]
Ò»¡¢ Ãû´Ê½âÊÍ£º Q:?]:i/*
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© B:qH7`s
2£® PCR£¨96£© QUd`({/@:
3£® ·ºËØ£¨ubquitin£©£¨96£© }8cL+JJU
4£® °é·Ö×Ó£¨chapron£©£¨96£© [O*5\&6
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© "e62g
6£® DG£IP3£¨96£© ,lSt}Lml
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© n[4F\I>
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© *qKPZb~
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© +r[u4?
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© @? 4-
11£® Transformation£¨92£© xZAc~~9tD
12£® TransfectionתȾ£¨92£© n%PHHu
13£® Transcytosis×ªÒÆ×÷Óã¨92£© HRO:U%
14£® Transductionתµ¼£¨92£© Q?Vq/3K;
15£® Transdetermination£¨92£© jSVIO v:
16£® Transdifferentiation£¨92£© D?~`L[}I!}
17£® Transgenic animalת»ùÒò¶¯Î92£© >#).3
18£® Rb£1£¨92£© M\zM-B
19£® P53£¨92¡¢91£© yVd}1bX
20£® C£jun£¨92£© O'y8[<
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© dWV.5cViP
22£® °ûÄÚÌ壨99£© h-u63b1"?
23£® Cyclin dependent kinase inhibitor(CDKI)(99) JK:i-
24£® G£protein£¨91£© T+p?VngF
25£® Restriction point£¨91£© ) jBPt&
26£® Antipost£¨91£© mX))*e4k
27£® Capping£¨91£© ximW!y7
28£® TATAbox£¨91£© u*:B 9E
29£® cDNA library£¨90£© Htd-E^/
30£® Aritotic apparatus£¨90£© "H I&dC
31£® ¿çĤÐźŠtransmembrane signal£¨90£© |uT|(:i84,
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© C}grY5:
33£® Nuclear lamina£¨90£© `j+aAxJ=\
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© TtA6N8G
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© Z_vIGH|1
36£® ϸ°û·Ö»¯£¨00£© yn=BO`sgW
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© 6qfL-( G
38£® ¿Ë¡£¨00£© NzB"u+jB
39£® »ùÒò×飨00£© feg
40£® Caspase£¨00£© =+24jHs
41£® ת¼Òò×Ó£¨00£© ph*9,\c8
42£® ÅßÌ¥¸Éϸ°û£¨01£© M*ZR+pq,
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© c^ $_
epc*
44£® DNAоƬ£¨01£© )BI6nU
¶þ¡¢ ÎÊ´ðÌ⣺ 1.p2{
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© WE;QEA /
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© _XLGXJ[B
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© zJC!M
eN
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© f|U;4{k
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© kpT>xS^6<
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© d.wu
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© 5]_m\ zn=
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© nymF`0HYe1
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© OR84/^>
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© @PH`Wn
#S
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© *4]u?R
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© z?T;2/_7
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© ^y"
#2Ov
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© QH
z3
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© *`D}voU
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© S87E$k
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© >9-$E?Mt
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© BQ8vg8e]B
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© v)+E!"R3.
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© 6}z-X*
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© V\
1pn7~V
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© &m{SWV+
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© l\f
/(&,
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© TH[xS
g
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© d_7v 1)j
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© ~&}e8ah2
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© {C>E*qp}f
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© azK7kM~
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© =6.4
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© !=uaB.
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© e4h9rF{Cxn
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© RIm8PV;N
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© 0|i3#G_~
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© 7\0}
te
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©